CTGF has been recently reported to play a role in tumorigenesis and its expression is elevated in various tumors including acute lymphoblastic leukemias [60], esophageal squamous cell carcinomas [61], pancreatic cancers [61], [62] and prostate cancer [63]. This evidence concerns the gene CCN2 and pancreatic neoplasm.